Abstract: This disclosure is concerned with novel techniques and circuit configurations for rendering high gain operational amplifiers and related differencing amplifiers adaptable for use with very low impedance signal sources to permit amplification of low-power signals with ultra-low noise, high D. C. stability, high gain, and wide frequency response, through development of the signal current as a very small increment on a much larger pre-existing current forced in opposite directions through an electronic switching device connected to such amplifier and producing minimal uncorrelated noise therein.

Abstract: This invention discloses a method of using galactose-binding lectins, such as Ricinus communis agglutinin I (RCA.sub.I), to kill cancer cells. RCA.sub.I has been found to severely weaken certain types of cancer cells, such as bladder carcinoma. This weakening can kill substantial numbers of cancer cells. In addition, it is possible to attach RCA.sub.I to other substances which impose stress on cells, such as cytotoxic drugs or enzymes that catalyze exothermic reactions, which can kill weakened cancer cells.

Abstract: An improved method for assaying for cancer by detecting .beta.-linked galactose moieties associated with cells is disclosed wherein a label specific for such moieties is added to the cells and subsequently sensed.

Abstract: There is disclosed a novel compact power oscillator which is normally quiescent until applied to a load, to produce, under load, a unique waveform which has a unique application to self-protective devices and medical uses. The oscillator includes a high gain inverting amplifier, preferably a Darlington pair constituted by a germanium output transistor driven by a small signal transistor, a transformer, a D.C. source such as a battery, and a pair of output electrodes.

Abstract: An enzymatic noninvasive method for detecting cancer in mammalian tissue is disclosed. This method comprises incubating exfoliated cells from mammalian tissue suspected of containing cancerous cells, and assaying them for galactosyl transferase activity. The level of galactosyl transferase activity has been found to be significantly altered in cells from cancerous tissue as compared to the level in cells from normal tissue.